Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / AMPE - Ampio inks research pact explore new indications for Ampion


AMPE - Ampio inks research pact explore new indications for Ampion

Ampio Pharmaceuticals ([[AMPE]] -5.9%) has entered into two collaborative research agreements to explore new clinical indications for its immunomodulatory drug, Ampion.Currently in clinical trials for treatment of inflammation due to osteoarthritis and COVID-19 related acute respiratory distress syndrome, Ampion has been shown to reduce inflammation through multiple pathways.Earlier this month, completed enrollment in a COVID-19 study evaluating inhaled Ampion

For further details see:

Ampio inks research pact explore new indications for Ampion
Stock Information

Company Name: Ampio Pharmaceuticals Inc.
Stock Symbol: AMPE
Market: OTC
Website: ampiopharma.com

Menu

AMPE AMPE Quote AMPE Short AMPE News AMPE Articles AMPE Message Board
Get AMPE Alerts

News, Short Squeeze, Breakout and More Instantly...